
Viridian Therapeutics, Inc.
USD18.79
+0.89 (+4.97%)
CEO
Stephen F. Mahoney
IPO Date
2014-06-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$19.37
Prev. Close
$17.90
Day Low
$18.24
Day High
$19.53
52W Low
$13.18
52W High
$34.29
Market Cap
$1.69B
Volume
7.59M
| 21 Apr 2026 |
| Truist Securities |
| Buy |
| Buy |
| maintain |
| 8 Apr 2026 | Wedbush | Outperform | Outperform | maintain |
| 7 Apr 2026 | Goldman Sachs | Buy | Buy | maintain |
| 7 Apr 2026 | RBC Capital | Outperform | Outperform | maintain |
| 2 Apr 2026 | Evercore ISI Group | Outperform | Outperform | maintain |
| 31 Mar 2026 | Wedbush | Outperform | Outperform | maintain |
| 31 Mar 2026 | Wells Fargo | Equal Weight | Equal Weight | maintain |